These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 3043397)
41. Scope of DNA cloning and chemical methods in development of chemotherapeutic agents. Narang SA; Brousseau R; Georges F Pharmacol Ther; 1984; 26(2):163-89. PubMed ID: 6085403 [No Abstract] [Full Text] [Related]
47. Megabase methods: a quantum jump in recombinant DNA techniques. Jordan BR Bioessays; 1988 May; 8(5):140-5. PubMed ID: 3044355 [No Abstract] [Full Text] [Related]
48. [EcoR1 restriction in vivo: possible utilization in genetic engineering]. Skavronskaia AG; Aleshkin GI; Demkin VV; Strikhanov SN; Evdokimova NM Vestn Akad Med Nauk SSSR; 1981; (2):40-6. PubMed ID: 6264708 [No Abstract] [Full Text] [Related]
49. [Gene technology and DNA diagnosis]. Matsubara K Rinsho Byori; 1987 Oct; 35(10):1069-71. PubMed ID: 3481414 [No Abstract] [Full Text] [Related]
50. [The study and correction of gene defects in hereditary diseases]. Neĭfakh SA Vestn Akad Med Nauk SSSR; 1981; (12):23-32. PubMed ID: 6949414 [No Abstract] [Full Text] [Related]
51. Diagnosis of human heritable defects by recombinant DNA methods. Caskey CT; Gibbs RA; Witkowski JA; Hejtmancik JF Philos Trans R Soc Lond B Biol Sci; 1988 Jun; 319(1194):353-60. PubMed ID: 2900528 [TBL] [Abstract][Full Text] [Related]
52. About recombinant deoxyribonucleic acid in medicine and industry. O'Malley BW; Jackson D Heart Lung; 1982; 11(1):93-8. PubMed ID: 6276336 [No Abstract] [Full Text] [Related]
53. Differential mRNA display. Adaption for in vivo studies of diseased tissues. Russell ME; Räisänen-Sokolowski A; Utans U Methods Mol Biol; 1997; 85():233-47. PubMed ID: 9276328 [No Abstract] [Full Text] [Related]
54. [Clinical genetics problems in the coming years]. Davidenkova EF Klin Med (Mosk); 1982 Mar; 60(3):3-9. PubMed ID: 6953282 [No Abstract] [Full Text] [Related]
55. Molecular basis of genetic disease and molecular methods. McPherson RA Clin Lab Med; 1995 Dec; 15(4):779-94. PubMed ID: 8838223 [TBL] [Abstract][Full Text] [Related]
56. Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage lambda-based recombination. Domi A; Moss B Nat Methods; 2005 Feb; 2(2):95-7. PubMed ID: 15782205 [TBL] [Abstract][Full Text] [Related]
57. Recombinant DNA technology and laboratory medicine. Rabson AB; Rabson AS Arch Pathol Lab Med; 1983 Oct; 107(10):505-9. PubMed ID: 6311140 [TBL] [Abstract][Full Text] [Related]
58. Genetic engineering of mammalian cells: its potential application to genetic diseases of man. Cline MJ J Lab Clin Med; 1982 Mar; 99(3):299-308. PubMed ID: 7035587 [No Abstract] [Full Text] [Related]
59. Engineering the immune system to cure genetic diseases, HIV, and cancer. Porteus MH; Fischer A Curr Opin Immunol; 2012 Oct; 24(5):576-9. PubMed ID: 23084086 [No Abstract] [Full Text] [Related]